What began as a medical intervention for diabetes has become a cultural tool for cosmetic weight loss, raising questions about supply allocation, long-term adherence (many regain weight after stopping), and societal standards for body image
In the SURMOUNT-1 trial, people taking the highest dose of tirzepatide (15mg weekly) lost an average of 22.5% of their body weight over 72 weeks
Despite robust clinical data and success stories from thousands of patients, were suddenly seeing headlines like: The Dark Side of GLP-1s Are Weight Loss Injections Destroying Your Body? Why This Miracle Drug Might Be a Nightmare But heres the thingmany of these alarming articles and videos arent written by physicians
and Fin (intragastrically administered 10 mg/kg Fin in 200 L saline)
Acetyl-L-Carnitine HCL -- All Letco APIs are of the highest pharmaceutical grade and comply, where applicable, with the current requirements of pharmacopoeial standards (USP-NF, BP, EP or equivalent)
Actions of GLP-1 on exocrine pancreas Infusion of GLP-1 to mimic postprandial levels inhibits pancreatic exocrine secretion in response to intragastric infusion of a liquid meal in man (127)
